How many clinical trials are tracked of degarelix?

31 trials are tracked, 1 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

degarelix

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of degarelix

31 trials tracked of degarelix: 11 in phase 3 or 4 and 1 with published results. The most-cited published study has 25 citations.

31Trials tracked

11Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 3 11 Phase 2 17 Other / NA 3

Phase 3 A Study of Degarelix in Patients With Prostate Cancer Completed · 25 cited
Phase 3 A Long Term Safety Study of Degarelix in Patients With Prostate Cancer Completed
Phase 3 The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer Completed
Phase 3 Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer Completed
Phase 3 A Trial of Degarelix in Patients With Prostate Cancer Completed
Phase 3 Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients Completed

Show 25 more trials

Phase 3 Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients Completed
Phase 3 An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer Completed
Phase 3 Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer Completed
Phase 3 A Study of Degarelix in Taiwanese Patients With Prostate Cancer Completed
Phase 3 Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer Completed
Phase 2 TRial on the Endocrine Activity of Neoadjuvant Degarelix Completed
Phase 2 Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia. Completed
Phase 2 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy Completed
Phase 2 Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer Completed
Phase 2 Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer Completed
Phase 2 Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization Completed
Phase 2 A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer Completed
Phase 2 Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer Completed
Phase 2 Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients Completed
Phase 2 A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy Completed
Phase 2 A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer Completed
Phase 2 The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer Completed
Phase 2 A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer Completed
Phase 2 Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy Completed
Phase 2 Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer. Completed
Phase 2 Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer Completed
Phase 2 Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 Completed
N/A Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland Completed
N/A Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer Completed
N/A Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer Completed

Showing the 31 most-cited and recently-updated of 31 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.